Sernova Corp (SVA : TSX)
Common Stock
$0.14
CAD
-0.01 (-6.45%)
Last updated: 2026-06-23
SVA
Sernova Corp
WealthAwesomePerformance
1 Day
-6.45%
1 Week
+3.57%
1 Month
-6.45%
YTD
+16.00%
Key Statistics
Market Cap
$56.03M
52W High
$0.21
52W Low
$0.12
P/E Ratio
-
50 Day MA
$0.16
200 Day MA
$0.16
Beta
0.66
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/23/2026 | $0.15 | $0.15 | $0.14 | $0.14 | $0.14 | 63,778 |
| 6/22/2026 | $0.16 | $0.16 | $0.15 | $0.15 | $0.15 | 78,770 |
| 6/19/2026 | $0.15 | $0.15 | $0.13 | $0.15 | $0.15 | 394,473 |
| 6/18/2026 | $0.17 | $0.17 | $0.15 | $0.16 | $0.16 | 121,662 |
| 6/17/2026 | $0.15 | $0.17 | $0.15 | $0.17 | $0.17 | 311,608 |
| 6/16/2026 | $0.16 | $0.16 | $0.14 | $0.14 | $0.14 | 48,300 |
| 6/15/2026 | $0.14 | $0.15 | $0.14 | $0.15 | $0.15 | 26,435 |
| 6/12/2026 | $0.15 | $0.15 | $0.14 | $0.14 | $0.14 | 129,330 |
| 6/11/2026 | $0.16 | $0.16 | $0.15 | $0.16 | $0.16 | 207,600 |
| 6/10/2026 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | 6,300 |
Analyst Price Targets
Based on analyst covering SVA
Wall Street analysts forecast SVA stock price to rise 210.3% over the next 12 months.
Consensus
No RatingAvg. Target
C$0.45
+210.3% Upside
Current Price
C$0.14
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on SVA's historical volatility
30-Day Vol
99.5%
Annualized
90-Day Vol
83.7%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.12
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.14 | C$0.10 – C$0.19 |
| 60 trading days | C$0.13 | C$0.08 – C$0.21 |
| 90 trading days | C$0.12 | C$0.07 – C$0.22 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Sernova Corp
Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is based in Mississauga, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-10.14M
- Profit Margin
- 0.00%
- ROE (TTM)
- -726.29%
- EPS (Diluted)
- -0.04
- Book Value
- -0.06
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About SVA
Articles Featuring SVA.TO
Latest articles and analysis covering SVA.TO
Why Sernova Corp stock is plummeting today
Sernova Corp's recent stock performance highlights significant investor concerns, particularly following a 6.45% drop in a single trading day. The company's financial maneuvers and management decisions are under scrutiny as it navigates a challenging market environment.
Why Sernova Corp stock is rising today
Sernova Corp's stock rose by 3.33% in the last trading session, reflecting investor optimism following recent financial strategies aimed at reducing debt.
Why Sernova Corp stock is plummeting today
Sernova Corp's stock has plummeted by 6.25% in the last trading session, raising concerns about its financial stability following a significant debt-to-equity conversion and management changes.
Why Sernova Corp stock is skyrocketing today
Sernova Corp's stock price surged by over 21% in the last trading session, driven by strong insider ownership and investor confidence in its growth potential.
Why Sernova Corp stock is skyrocketing today
Sernova Corp's stock surged by 7.14% today, driven by strong insider ownership and growth potential. With a market cap of CA$56 million, the company is attracting attention from investors looking for promising opportunities.
Why Sernova Corp stock is plummeting today
Sernova Corp's stock suffered a notable drop today, closing at CA$0.14, down 9.68%. This decline raises questions about the company's future amid a challenging market environment.
Why Sernova Corp stock is plummeting today
Sernova Corp's stock plummeted by 9.38% today, closing at CA$0.14. This decline raises questions about the company's future prospects, especially in a challenging economic landscape.
Why Sernova Corp stock is plummeting today
Sernova Corp's stock has plummeted by 9.38% in the latest trading session, closing at CA$0.14. This decline raises concerns about the company's future amidst a backdrop of high insider ownership and growth potential.
Why Sernova Corp stock is sliding today
Sernova Corp's stock price dropped by 3.13% in the latest session, reflecting investor concerns despite its promising growth metrics.
Why Sernova Corp stock is rising today
Sernova Corp's stock rose by 3.33% in the last trading session, driven by strong investor confidence and its high insider ownership. With a market cap of CA$52 million and promising earnings growth, Sernova is becoming a notable player in the TSX.
Why Sernova Corp stock is skyrocketing today
Sernova Corp's stock has surged by 6.67% today, driven by strong insider ownership and promising earnings growth forecasts, making it a standout performer on the TSX.
10 Best Canadian Biotech Stocks (Jun 2026)
Biotech has been one of the most promising engines of innovation in the field of healthcare and medicine. Consequently, it's also an avenue where a lot of big money is moving in (institutional investors, government funding, etc.). The global biotech market size is expected to reach a trillion dollar
![10 Best Canadian Biotech Stocks ([currentmonthyear])](https://lhajohzwizrsjmumhpjg.supabase.co/storage/v1/object/public/wealth-awesome/site-media/best-canadian-biotech-stocks_8-1.jpg)